Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib

Arch Dermatol. 2012 Jun;148(6):683-5. doi: 10.1001/archdermatol.2011.2819.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / administration & dosage
  • Benzenesulfonates / therapeutic use*
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / pathology
  • Hemangiosarcoma / drug therapy*
  • Hemangiosarcoma / pathology
  • Humans
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use*
  • Scalp
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Sorafenib
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib